Clinical Trial

Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pilot randomized control trial (RCT) to explore the effects of hydrogen rich water on quality of life in patients with high grade gliomas, receiving focal radiation therapy to the brain concurrent with chemotherapy with Temozolomide.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-11-21; most recent amendment 2025-07-24.
Status change: Recruiting → Active, Not Recruiting 2024-03-07
Trial Details
NCT Number NCT04175301
Lead Sponsor Stony Brook University
Conditions Malignant Glioma
Enrollment 15 participants
Start Date 2019-10-31
Primary Completion 2026-09-05 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-29